These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29960767)

  • 21. A Composite Endpoint for Acceptability Evaluation of Oral Drug Formulations in the Pediatric Population.
    Wargenau M; Reidemeister S; Klingmann I; Klingmann V
    Ther Innov Regul Sci; 2022 Nov; 56(6):903-909. PubMed ID: 35471561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acceptability of oral liquid pharmaceutical products in older adults: palatability and swallowability issues.
    Belissa E; Vallet T; Laribe-Caget S; Chevallier A; Chedhomme FX; Abdallah F; Bachalat N; Belbachir SA; Boulaich I; Bloch V; Delahaye A; Depoisson M; Wojcicki AD; Gibaud S; Grancher AS; Guinot C; Lachuer C; Lechowski L; Leglise P; Mahiou A; Meaume S; Michel C; Michelon H; Orven Y; Perquy I; Piccoli M; Rabus M; Ribemont AC; Rwabihama JP; Trouvin JH; Ruiz F; Boudy V
    BMC Geriatr; 2019 Dec; 19(1):344. PubMed ID: 31810442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of swallowability and palatability of oral dosage forms in children: Report from an M-CERSI pediatric formulation workshop.
    Ternik R; Liu F; Bartlett JA; Khong YM; Thiam Tan DC; Dixit T; Wang S; Galella EA; Gao Z; Klein S
    Int J Pharm; 2018 Feb; 536(2):570-581. PubMed ID: 28844897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of Different Liquid and Semisolid Vehicles Selected for Oral Administration of Pellets and Minitablets with Diazepam: In Vitro Investigation.
    Kotlowska H; Szymanska M; Sznitowska M
    AAPS PharmSciTech; 2020 Jul; 21(6):213. PubMed ID: 32737624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Minitablets current use and future opportunities - An APV course on manufacturing, packaging, characterization and use of minitablets.
    Page S; Rode T; Breitkreutz J; Wagner-Hattler L
    Eur J Pharm Biopharm; 2024 Jun; 199():114294. PubMed ID: 38636884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acceptability, Swallowability, Palatability, and Safety of Multiple Film-Coated Mini-Tablets in Children Aged ≥2-<7 Years: Results of an Open-Label Randomised Study.
    Münch J; Kloft C; Farhan M; Fishman V; Leng S; Bosse HM; Klingmann V
    Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36840023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Age-appropriate and acceptable paediatric dosage forms: Insights into end-user perceptions, preferences and practices from the Children's Acceptability of Oral Formulations (CALF) Study.
    Ranmal SR; Cram A; Tuleu C
    Int J Pharm; 2016 Nov; 514(1):296-307. PubMed ID: 27863675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of three doses of a commercially prepared oral midazolam syrup in children.
    Coté CJ; Cohen IT; Suresh S; Rabb M; Rose JB; Weldon BC; Davis PJ; Bikhazi GB; Karl HW; Hummer KA; Hannallah RS; Khoo KC; Collins P
    Anesth Analg; 2002 Jan; 94(1):37-43, table of contents. PubMed ID: 11772797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of healthcare resource and cost implications of using alternative sodium valproate formulations in the treatment of epilepsy in children in England: A retrospective database review.
    Batchelor H
    Eur J Pharm Biopharm; 2021 Jan; 158():365-370. PubMed ID: 33338602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application properties of oral gels as media for administration of minitablets and pellets to paediatric patients.
    Kluk A; Sznitowska M
    Int J Pharm; 2014 Jan; 460(1-2):228-33. PubMed ID: 24216119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Development of Minitablets for a Pediatric Dosage Form for a Combination Therapy.
    Zhang D; Rumondor ACF; Zhu W; Colace T; Marota M; Mora J; Liu Z; Li Y
    J Pharm Sci; 2020 Dec; 109(12):3590-3597. PubMed ID: 32882230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acceptability of different oral dosage forms in paediatric patients in hospital setting.
    Pokharkar V; Sajith M; Vallet T; Akshantal S; Shah R; Ruiz F; Salunke S
    Arch Dis Child; 2022 Sep; 107(9):796-801. PubMed ID: 34799375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Designs of clinical swallowability assessments of solid oral dosage forms in regulatory submissions.
    McGuire MR; Mostofa A; Shon J; Frost M; Kim MJ; Li K
    Int J Pharm; 2024 Jun; 659():124229. PubMed ID: 38762166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel soft robotic pediatric in vitro swallowing device to gain insights into the swallowability of mini-tablets.
    Lavoisier A; Avila-Sierra A; Timpe C; Kuehl P; Wagner L; Tournier C; Ramaioli M
    Int J Pharm; 2022 Dec; 629():122369. PubMed ID: 36351507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single-dose pharmacokinetics of pediatric and adult formulations of etravirine and swallowability of the 200-mg tablet: results from three Phase 1 studies.
    Kakuda TN; Berckmans C; De Smedt G; Leemans R; Leopold L; Peeters M; Nijs S; Vyncke V; van Solingen-Ristea R; Hoetelmans RM
    Int J Clin Pharmacol Ther; 2013 Sep; 51(9):725-37. PubMed ID: 23924679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Minitablets: new modality to deliver medicines to preschool-aged children.
    Thomson SA; Tuleu C; Wong IC; Keady S; Pitt KG; Sutcliffe AG
    Pediatrics; 2009 Feb; 123(2):e235-8. PubMed ID: 19171575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of Solid Oral Dosage Form Characteristics on Swallowability, Visual Perception, and Handling in Older Adults.
    Hummler H; Page S; Stillhart C; Meilicke L; Grimm M; Mannaa M; Gollasch M; Weitschies W
    Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multi-Analytical Framework to Assess the In Vitro Swallowability of Solid Oral Dosage Forms Targeting Patient Acceptability and Adherence.
    Ershad AL; Rajabi-Siahboomi A; Missaghi S; Kirby D; Mohammed AR
    Pharmaceutics; 2021 Mar; 13(3):. PubMed ID: 33808875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pediatric pharmacodynamics of midazolam oral syrup. Pediatric Pharmacology Research Unit Network.
    Marshall J; Rodarte A; Blumer J; Khoo KC; Akbari B; Kearns G
    J Clin Pharmacol; 2000 Jun; 40(6):578-89. PubMed ID: 10868308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atovaquone + proguanil: new indication. For children weighing as little as 5 kg; an inconvenient form. A flavoured syrup would be better suited to infants and young children.
    Prescrire Int; 2009 Jun; 18(101):113. PubMed ID: 19637424
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.